GlassScriptPhysician profile
Benjamin R Waller
NPI 1013974062
$52,434.35
in general payments reported to CMS, 2019-2025
8 companies · $7,817 in 2025
The $7,817 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $188 · 2021: $7,834 · 2022: $20K · 2023: $7,802 · 2024: $8,894 · 2025: $7,817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Food and Beverage: $1,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,115.00 |
| Food and Beverage | $1,397.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $48,856.80 | 2021-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder, Gore Viabahn Vbx Balloon Expandable Endo |
| Abbott Laboratories | $2,552.45 | 2019-2023 | Amplatzer Piccolo |
| Medtronic, INC. | $281.60 | 2021-2025 | Corevalve Evolut R |
| Actelion Pharmaceuticals US, INC. | $267.52 | 2023-2025 | Opsumit, Uptravi |
| Edwards Lifesciences Corporation | $203.64 | 2020-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Hemosphere |
| Medtronic Vascular, INC. | $123.14 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.68 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.52 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Waller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.